Literature DB >> 2331781

The developmental expression of the cholinergic-specific antigen Chol-1 in the central and peripheral nervous system of the rat.

E A Derrington1, E Borroni.   

Abstract

Antisera raised by the injection into sheep of presynaptic plasma membranes isolated from the purely cholinergic electromotor nerve terminals of Torpedo marmorata recognize a cholinergic-specific epitope, designated Chol-1 which has been shown to be gangliosidic in nature both in Torpedo (Richardson et al., 1982) and guinea-pig brain (Ferretti and Borroni, 1986). In rat brain the serum recognizes a group of antigenically-related minor gangliosides (Chol-1 alpha, beta and gamma) which migrate just below the standard gangliosides GQ, GT1B and between GD1b and GD1a, respectively. We have studied the developmental expression of these gangliosides in rat brain and hippocampus and in the neuromuscular junction of rat intercostal muscle in an attempt to correlate their expression with specific events in the development of the cholinergic neuron. The period in which Chol-1 is first detected suggests that it is expressed relatively late during the maturation process of the cholinergic synapse. This is supported by the finding: (a) that it is not detected in the growth cones (immature nerve terminals) in 5-day-old rat brain but is in the whole brain implying that only the more mature nerve terminals present at this stage express Chol-1; and (b) that Chol-1 is first expressed in the neuromuscular junction at a time in which functional synapses are already present. These results argue against a role for the Chol-1 antigens as recognition molecules in the formation of cholinergic synapses. The expression of Chol-1 in both the hippocampus and the neuromuscular junction correlates well with the establishment of the adult pattern of innervation; thus the Chol-1 antigens may be seen as markers for mature cholinergic terminals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331781     DOI: 10.1016/0165-3806(90)90228-q

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  12 in total

Review 1.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

Review 2.  Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.

Authors:  Jaap J Plomp; Hugh J Willison
Journal:  J Physiol       Date:  2009-06-29       Impact factor: 5.182

Review 3.  Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses.

Authors:  Julie M Miwa; Robert Freedman; Henry A Lester
Journal:  Neuron       Date:  2011-04-14       Impact factor: 17.173

Review 4.  Gangliosides in Nerve Cell Specification.

Authors:  Yutaka Itokazu; Jing Wang; Robert K Yu
Journal:  Prog Mol Biol Transl Sci       Date:  2018-01-17       Impact factor: 3.622

Review 5.  The role of APP proteolytic processing in lipid metabolism.

Authors:  Marcus O W Grimm; Tatjana L Rothhaar; Tobias Hartmann
Journal:  Exp Brain Res       Date:  2011-12-17       Impact factor: 1.972

6.  Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain.

Authors:  Toshio Ariga; Makoto Yanagisawa; Chandramohan Wakade; Susumu Ando; Jerry J Buccafusco; Michael P McDonald; Robert K Yu
Journal:  ASN Neuro       Date:  2010-10-04       Impact factor: 4.146

Review 7.  The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.

Authors:  Toshio Ariga
Journal:  Mol Neurobiol       Date:  2017-01       Impact factor: 5.590

Review 8.  Cholinergic-specific glycoconjugates.

Authors:  V P Whittaker; S Kelić
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

9.  Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1aα.

Authors:  Toshio Ariga; Yutaka Itokazu; Michael P McDonald; Yoshio Hirabayashi; Susumu Ando; Robert K Yu
Journal:  ASN Neuro       Date:  2013-05-30       Impact factor: 4.146

10.  Anti-Chol-1 antigen, GQ1bα, antibodies are associated with Alzheimer's disease.

Authors:  Toshio Ariga; Masaru Kubota; Makoto Nakane; Kenji Oguro; Robert K Yu; Susumu Ando
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.